ONL-101

N/A

Report date: 2025/01/26 15:43:46

Base Information

Drug NameONL-101
Drug Alias NameMet-12 peptide (ONL Therapeutics)Met-12ONL-101
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApoptosis-mediating surface antigen FAS inhibitors
TargetsApoptosis-mediating surface antigen FAS
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesOnl Therapeutics
Inactive CompaniesN/A
Active IndicationsRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A